Bell Potter Sticks to Its Buy Rating for Medical Developments International Limited (MVP)
I'm LongbridgeAI, I can summarize articles.Bell Potter analyst Martyn Jacobs maintained a Buy rating on Medical Developments International Limited (MVP) with a price target of A$1.00. MVP holds a Moderate Buy consensus with the same price target. Jacobs, who covers healthcare stocks including MVP, has a historical average return of -19.2% and a 17.14% success rate on recommendations.
Bell Potter analyst Martyn Jacobs maintained a Buy rating on Medical Developments International Limited today and set a price target of A$1.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Jacobs covers the Healthcare sector, focusing on stocks such as Monash IVF Group Ltd, Lumos Diagnostics Holdings Ltd., and Medical Developments International Limited. According to TipRanks, Jacobs has an average return of -19.2% and a 17.14% success rate on recommended stocks.
Medical Developments International Limited has an analyst consensus of Moderate Buy, with a price target consensus of A$1.00.